- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03240536
Choosing Tests Wisely in Rheumatology
April 19, 2022 updated by: Lawson Health Research Institute
This is a randomized study intended to produce a reduction in ordering of inappropriate tests by general practitioners as determined by recommendations from the CRA's Choosing Wisely guidelines.
This reduction of inappropriate testing is expected in referrals to the rheumatologists randomized to the intervention group.
This study will further explore which recommendations from the Canadian Rheumatology Association (CRA)/Canada Choosing Wisely campaign have the most impact on regional referring physicians to the Rheumatology clinic at St. Joseph's Hospital, London.
Study Overview
Detailed Description
This a randomized study in that 6 rheumatologists (30 referrals each) will be randomized to one of two groups: intervention or control.
Referring physicians to the intervention group will be faxed a brief Choosing Wisely form (intervention) based upon the recommendations of the Canadian Rheumatology Association's (CRA) Canada Choosing Wisely campaign, while referring physicians from the control group will not receive the form (non intervention).
Analysis will be based upon the results of a three question survey faxed to all referring physicians at year one and at year two and on future referrals from the referring physicians to determine if there is a reduction in the group of ordering physicians that received the intervention (Choosing Wisely form).
Study Type
Interventional
Enrollment (Actual)
638
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A4V2
- St. Joseph's Health Care London
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ordering physicians who recently made a referral to the Rheumatology clinic at St. Joseph's Health Care.
Exclusion Criteria:
- N/A, all recent referrals will be included.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Ordering physicians who have referred to a rheumatologist in the St. Joseph's rheumatology clinic randomized to the intervention group will receive a brief Choosing Wisely form (for education of guidelines) faxed with the referral notice.
At one and two years all ordering physicians will receive by fax a three question survey.
|
The investigators will fax a "Choosing Wisely form" to ordering physicians that will include information from the Canadian Rheumatology Association Canada Choosing Wisely Guidelines. Three points will be included with some additional explanation of why these are important. The three guidelines included will be:
|
|
No Intervention: Control Group
Ordering physicians who have referred to rheumatologists in the control group will not receive the Choosing Wisely form.
At one and two years all ordering physicians will receive by fax a three question survey.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessing the change in the number of the total number of ANA tests, back CT's and shoulder ultrasounds in rheumatology referrals
Time Frame: Change from baseline number of tests at year one, year two
|
-collecting the total number of ANA tests, back CT's and shoulder ultrasounds
|
Change from baseline number of tests at year one, year two
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2018
Primary Completion (Actual)
September 8, 2021
Study Completion (Actual)
September 8, 2021
Study Registration Dates
First Submitted
July 27, 2017
First Submitted That Met QC Criteria
August 2, 2017
First Posted (Actual)
August 7, 2017
Study Record Updates
Last Update Posted (Actual)
April 26, 2022
Last Update Submitted That Met QC Criteria
April 19, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 109363
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on SLE
-
Assiut UniversityUnknown
-
Assiut UniversityNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
Polyclinic of the Hospitaller Brothers of St. John...Szeged University; University of DebrecenCompleted
-
Ruitherapeutics Co., LTDNot yet recruiting
-
BiogenCompletedSystemic Lupos Erythematosus, SLEUnited States
-
Assiut UniversityNot yet recruitingSLE (Systemic Lupus)Egypt
-
AstraZenecaActive, not recruitingDescription of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan | Description of the Course of SLE in Patients in the Republic of Kazakhstan | Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of KazakhstanKazakhstan
Clinical Trials on Choosing Wisely form
-
Karolinska InstitutetVastra Gotaland Region; Region Jönköping County; Region Skane; Region Stockholm; Uppsala-Örebro... and other collaboratorsRecruitingCritical Illness | Ventilation | Acute Kidney Injury | Dialysis | OutcomeSweden
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); Ontario Agency for Health Protection... and other collaboratorsCompleted
-
Brown UniversityNational Institute on Drug Abuse (NIDA); Rhode Island HospitalCompletedSubstance Use | Adolescent BehaviorUnited States
-
University of Social Sciences and Humanities, WarsawActive, not recruitingOverweight and ObesityPoland
-
Washington University School of MedicineThe Jennings School DistrictCompletedChildhood Mental DisorderUnited States
-
Ohio State UniversityCompletedParenting | Mental Disorder in Adolescence | Adolescent - Emotional ProblemUnited States
-
Rhode Island HospitalUnknown
-
Anhui Provincial HospitalFuyang people's hospital; The First Affiliated Hospital of Bengbu Medical University and other collaboratorsNot yet recruitingCranioplasty | Ventriculoperitoneal Shunt (VPS)China
-
Family Works IncorporatedOregon Research InstituteCompletedParenting | DelinquencyUnited States
-
Assistance Publique Hopitaux De MarseilleUnknownPatient Having a CancerFrance